194 related articles for article (PubMed ID: 15582885)
1. [Locoregional recurrence of ovarian cancer: the place of surgery].
Classe JM; Catala L; Marchal F; Ferron G; Dravet F; Pioud R; Descamps P
Bull Cancer; 2004 Nov; 91(11):827-32. PubMed ID: 15582885
[TBL] [Abstract][Full Text] [Related]
2. Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature.
Bristow RE; Lagasse LD; Karlan BY
Cancer; 1996 Nov; 78(10):2049-62. PubMed ID: 8918397
[TBL] [Abstract][Full Text] [Related]
3. Surgery for recurrent ovarian cancer.
Rose PG
Semin Oncol; 2000 Jun; 27(3 Suppl 7):17-23. PubMed ID: 10952122
[TBL] [Abstract][Full Text] [Related]
4. [Secondary debulking surgery and intraperitoneal chemotherapy in advanced or recurrent epithelial ovarian cancer].
Plaisant N; Quenet F; Fabbro M; Gourgou S; Gutowski M; Saint-Aubert B; Rouanet P
Gynecol Obstet Fertil; 2004 May; 32(5):391-7. PubMed ID: 15177208
[TBL] [Abstract][Full Text] [Related]
5. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer.
Munkarah AR; Coleman RL
Gynecol Oncol; 2004 Nov; 95(2):273-80. PubMed ID: 15491746
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer.
Sugarbaker PH
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):15-24. PubMed ID: 19124999
[TBL] [Abstract][Full Text] [Related]
7. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
Harter P; du Bois A; Hahmann M; Hasenburg A; Burges A; Loibl S; Gropp M; Huober J; Fink D; Schröder W; Muenstedt K; Schmalfeldt B; Emons G; Pfisterer J; Wollschlaeger K; Meerpohl HG; Breitbach GP; Tanner B; Sehouli J; ;
Ann Surg Oncol; 2006 Dec; 13(12):1702-10. PubMed ID: 17009163
[TBL] [Abstract][Full Text] [Related]
8. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
9. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
Chi DS; McCaughty K; Diaz JP; Huh J; Schwabenbauer S; Hummer AJ; Venkatraman ES; Aghajanian C; Sonoda Y; Abu-Rustum NR; Barakat RR
Cancer; 2006 May; 106(9):1933-9. PubMed ID: 16572412
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.
Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB; Ivanovic AM; Kecmanovic DM
Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887
[TBL] [Abstract][Full Text] [Related]
11. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer.
Rufián S; Muñoz-Casares FC; Briceño J; Díaz CJ; Rubio MJ; Ortega R; Ciria R; Morillo M; Aranda E; Muntané J; Pera C
J Surg Oncol; 2006 Sep; 94(4):316-24. PubMed ID: 16917864
[TBL] [Abstract][Full Text] [Related]
12. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.
Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S
J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820
[TBL] [Abstract][Full Text] [Related]
13. Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome.
Karam AK; Santillan A; Bristow RE; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Li AJ
Gynecol Oncol; 2007 Feb; 104(2):377-80. PubMed ID: 17014899
[TBL] [Abstract][Full Text] [Related]
14. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
15. [Current surgical management in ovarian cancer recurrences].
Tinelli FG; Tinelli A; Campagnutta E; Kobal B; Rakar S; Manca C; Tinelli R; Perrone A
Minerva Ginecol; 2004 Oct; 56(5):457-67. PubMed ID: 15531862
[TBL] [Abstract][Full Text] [Related]
16. [Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].
Ferron G; Martinez A; Mery E; Querleu D; Thomas F; Chatelut E; Gladieff L
Bull Cancer; 2009 Dec; 96(12):1243-52. PubMed ID: 19948452
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of recurrent ovarian cancer.
Leitao MM; Chi DS
Semin Oncol; 2009 Apr; 36(2):106-11. PubMed ID: 19332245
[TBL] [Abstract][Full Text] [Related]
18. The role of secondary cytoreductive surgery in epithelial ovarian malignancies.
Williams L
Oncology (Williston Park); 1992 Aug; 6(8):25-32; discussion 37-9. PubMed ID: 1386995
[TBL] [Abstract][Full Text] [Related]
19. Second-line treatment of first relapse recurrent ovarian cancer.
Chua TC; Liauw W; Robertson G; Morris DL
Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):465-71. PubMed ID: 21039382
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]